Smiling Young Boy Visiting His Pediatrician

Moving Toward Early Diagnosis

Population-based screening for risk factors could help change the course of type 1 diabetes Researchers have known for some time that the risk of developing type 1 diabetes (T1D) can be detected by looking for the presence of specific autoantibodies. That knowledge has allowed JDRF to support TrialNet, a project that screens close relatives of people […]

Discovering the Best Size and Shape for Beta Cell Replacement

Discovering the Best Size and Shape for Beta Cell Replacement

Watch this: To learn more from MIT’s Dr. Anderson. Smaller Is Not Always Stealthier In a recent Nature Materials’ publication, Daniel Anderson, Ph.D., of the Massachusetts Institute of Technology (MIT) detailed how the immune system responds to implanted material depending on its size and shape. In this short video, you can learn about the future […]

Sernova Corp. and MGH to Collaborate with Funding from JDRF

Sernova Corp. Announces Collaboration with Massachusetts General Hospital to Develop Novel Diabetes Treatment with Funding Support from JDRF LONDON, ONTARIO (Marketwire – July 7, 2015) – Sernova Corp. (TSX-V: SVA; FRA: PSH), is pleased to announce a research collaboration with Massachusetts General Hospital, supported with funding from JDRF to develop a novel treatment for diabetes. […]

White House Honors Tidepool for Its Development of T1D Data Technology

New apps help simplify T1D management Tidepool™—a JDRF-supported nonprofit committed to reducing the burden of type 1 diabetes (T1D)—has received a White House Champion of Change Precision Medicine Award for its work to develop innovative, open-source software and mobile phone apps that help people with T1D better manage the disease. The technologies will provide tools […]

One Drug’s To-Do List Could Grow

An osteoporosis medication could help restore insulin production in people with type 1 diabetes Type 1 diabetes (T1D) is caused by an autoimmune attack on insulin-producing beta cells, but studies have shown that many adults with long-term T1D are able to maintain some of their beta cells. One potential approach to curing the disease is […]

JDRF Response to CrossFit

At JDRF, we don’t believe diabetes is a laughing matter or something to be joked about. During the week of June 29, CrossFit posted insensitive images and misleading information regarding diabetes, both type 1 and type 2. JDRF chose to take a positive approach and educate the members of the CrossFit social media team on the differences […]

JDRF Top Research Advances

The past year brought about significant advances in type 1 diabetes (T1D) therapies that are improving how people live with the disease and bringing us closer to a biological cure and universal advances that have helped make this a pivotal moment in the history of T1D research. ENCAPSULATION The JDRF Encapsulation Program funds development of […]

2015 Annual Meeting and Awards Ceremony

Join us at the JDRF New England Chapter’s 2015 Annual Meeting and Awards Ceremony Wednesday, June 17, 2015 6 – 9 p.m. Sheraton Needham Hotel 100 Cabot Street Needham, MA 02494 On this evening, we’ll take a look ahead, as well as offer thanks to you, our volunteers and donors, for your support. Your passion […]

2015 Annual Meeting and Awards Ceremony

Join us at the JDRF New England Chapter’s 2015 Annual Meeting and Awards Ceremony Wednesday, June 17, 2015 6 – 9 p.m. Sheraton Needham Hotel 100 Cabot Street Needham, MA 02494 On this evening, we’ll take a look ahead, as well as offer thanks to you, our volunteers and donors, for your support. Your passion […]

Well-Timed AP Technology Offers Peace of Mind in the UK

A JDRF-funded study at the University of Cambridge showed that an overnight treat-to-range device improved glucose control A recent JDRF-funded study at the University of Cambridge has found that unsupervised, at-home use of a treat-to-range artificial pancreas system can improve blood-glucose control throughout the night and into the next day. You can click on the […]